Baltimore, Maryland

Baltimore, Maryland 21287

0 studies enrolling now · 3 studies all time

What they study most

Diabetic Macular Edema (DME), Seizures

Studies at this site

• A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures — Stopped early
• A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures — Completed